Aurinia Pharmaceuticals shows steady Lupkynis sales growth. Read more on AUPH's Q1 '25 earnings, management change and ...

OCI N.V. retains a Hold rating as its focus on European nitrogen fertilizers, debt reduction, and improved market conditions ...

Gross margin improved by 1.9 point, reaching 53% over the year Positive EBITDA of €0.5 million, despite a decline in 2024 revenue to €57.1 million, compared with €82.5 million in 2023 Net ...

Q1 2025 revenue Quarterly activity Revenue: €180.1m, down 7.1% at CER1 and on a like-for-like basis2As expected, a first ...

Flat first-quarter gaming revenue has Macau bracing for a budget deficit. But China stimulus measures may increase consumer ...

On April 17, Joyce Chang, JPMorgan chair of global research, appeared on CNBC’s ‘Closing Bell Overtime’ to talk about ...

This followed a full-year growth of 11.21% (8.14% inflation-adjusted) in 2024 and 8.16% (4.9% inflation-adjusted) in 2023. Quarter-on-quarter ... Golden Visas granted to foreigners were just 162 in H2 ...

The Motley Fool. DATE Thursday, Apr 24, 2025 Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Mark Crossley: Chief Executive ...

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

The Motley Fool. DATE Thursday, Apr 24, 2025 Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Joe Hanna: Chief Executive ...

Stability in Q1 2025 turnover Adjusted turnover1 of €742m, stable versus Q1 2024, reflecting a negative volume/mix effect (-5%), offset by positive ...

Epiminder, a pioneering medical device and information solutions company, today announced that it has been granted FDA authorisation via the De Novo classification for Minder, its proprietary ...